What is a stock summary page? Click here for an overview.
Business Description
Becton, Dickinson and Co
NAICS : 339112
SIC : 3841
ISIN : US0758872081
Compare
Compare
Traded in other countries / regions
BDX.USA0R19.UKBOX.GermanyBDX.MexicoBDX.Austria1BDX.ItalyB1DX34.BrazilBDX.SwitzerlandBDX-RM.Russia IPO Date
2017-05-10Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.74 | |||||
| Debt-to-EBITDA | 3.86 | |||||
| Interest Coverage | 5.05 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.3 | |||||
| Beneish M-Score | -2.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.9 | |||||
| 3-Year EBITDA Growth Rate | 3.3 | |||||
| 3-Year EPS without NRI Growth Rate | 28.5 | |||||
| 3-Year FCF Growth Rate | -3.7 | |||||
| 3-Year Book Growth Rate | 2.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 8.95 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.97 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -14.25 | |||||
| 12-1 Month Momentum % | -8.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.13 | |||||
| Quick Ratio | 0.63 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 112.93 | |||||
| Days Sales Outstanding | 46.31 | |||||
| Days Payable | 57.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.17 | |||||
| 3-Year Dividend Growth Rate | 4.6 | |||||
| Forward Dividend Yield % | 5.17 | |||||
| 5-Year Yield-on-Cost % | 6.41 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | -0.62 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.22 | |||||
| Operating Margin % | 13.99 | |||||
| Net Margin % | 8.37 | |||||
| ROE % | 6.75 | |||||
| ROA % | 3.15 | |||||
| ROIC % | 5.47 | |||||
| 3-Year ROIIC % | 3.8 | |||||
| ROC (Joel Greenblatt) % | 30.74 | |||||
| ROCE % | 5.35 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.79 | |||||
| Forward PE Ratio | 29.79 | |||||
| PE Ratio without NRI | 16.36 | |||||
| Shiller PE Ratio | 45.06 | |||||
| Price-to-Owner-Earnings | 23.77 | |||||
| PEG Ratio | 3.48 | |||||
| PS Ratio | 3.2 | |||||
| PB Ratio | 2.59 | |||||
| Price-to-Free-Cash-Flow | 22.53 | |||||
| Price-to-Operating-Cash-Flow | 18.12 | |||||
| EV-to-EBIT | 33.01 | |||||
| EV-to-EBITDA | 17.16 | |||||
| EV-to-Revenue | 4.04 | |||||
| EV-to-FCF | 28.4 | |||||
| Earnings Yield (Greenblatt) % | 3.03 | |||||
| FCF Yield % | 4.49 | |||||
| Forward Rate of Return (Yacktman) % | 8.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BDXA.PFD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Becton, Dickinson and Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.15 | ||
| 3-Year Sortino Ratio | 0.22 | ||
| Volatility % | 8.86 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | -8.72 | ||
| 52-Week Range ($) | 49.07 - 68.35 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Becton, Dickinson and Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Becton, Dickinson and Co Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Becton, Dickinson and Co Frequently Asked Questions
What is Becton, Dickinson and Co(BDXA.PFD)'s stock price today?
The current price of BDXA.PFD is $59.24. The 52 week high of BDXA.PFD is $68.35 and 52 week low is $49.07.
When is next earnings date of Becton, Dickinson and Co(BDXA.PFD)?
The next earnings date of Becton, Dickinson and Co(BDXA.PFD) is 2025-05-01.
Does Becton, Dickinson and Co(BDXA.PFD) pay dividends? If so, how much?
The Dividend Yield %  of Becton, Dickinson and Co(BDXA.PFD) is 5.17% (As of Today), Highest Dividend Payout Ratio of Becton, Dickinson and Co(BDXA.PFD) was 1.71. The lowest was 0.29. And the median was 0.52. The  Forward Dividend Yield % of Becton, Dickinson and Co(BDXA.PFD) is 5.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers